Showing results (1-10 of 475) with videos related to
Sort By:
Pageof 48
Therapeutics and Clinical Risk Management|February 23, 2011
Role of rituximab in first-line treatment of chronic lymphocytic leukemiaJeffrey Bryan, Gautam BorthakurExpert Opinion on Investigational Drugs|August 8, 2018
Investigational CHK1 inhibitors in early stage clinical trials for acute myeloid leukemiaKamal Chamoun, Gautam BorthakurExpert Review of Hematology|November 18, 2020
Apoptosis targeted therapies in acute myeloid leukemia: an updateSomedeb Ball, Gautam BorthakurExpert Opinion on Investigational Drugs|January 16, 2013
Lenalidomide as a novel treatment of acute myeloid leukemiaYiming Chen, Gautam BorthakurExpert Review of Hematology|March 29, 2018
Checkpoint inhibitors and acute myelogenous leukemia: promises and challengesMansour Alfayez, Gautam BorthakurBlood Cancer Journal|June 17, 2021
Core binding factor acute myelogenous leukemia-2021 treatment algorithmGautam Borthakur, Hagop KantarjianExpert Review of Hematology|June 25, 2019
Novel treatments for relapsed/refractory acute myeloid leukemia with FLT3 mutationsEran Tallis, Gautam BorthakurCancer Drug Resistance (Alhambra, Calif.)|October 16, 2023
Targeting metabolic vulnerabilities to overcome resistance to therapy in acute myeloid leukemiaPriyanka Sharma, Gautam BorthakurExpert Opinion on Emerging Drugs|May 17, 2017
Emerging cell cycle inhibitors for acute myeloid leukemiaAbdallah Abou Zahr, Gautam BorthakurPageof 48